ArticleBMC oral health2025
A machine learning-based risk prediction model for diabetic oral ulceration.
Article in BMC oral health, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Development and validation of a nomogram for predicting fasciotomy requirement in lower extremity arterial injuries: a retrospective case-control study.Journal of orthopaedics and traumatology : official journal of the Italian Society of Orthopaedics and Traumatology · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
Abstract
backgroundDiabetic oral ulceration (DOU) is a prevalent and debilitating complication among diabetic patients, significantly impairing their quality of life and imposing substantial economic burdens. Studies indicate that over 90% of diabetic patients experience oral complications, with 45% suffering from oral ulcers. Clear diagnosis is crucial for effective clinical management and prognosis improvement. However, current diagnostic methods often fall short in early detection and intervention. Machine learning (ML) has shown promise in predicting disease development, yet no relevant predictive models for DOU have been established.
methodsThis study aimed to develop an ML-based predictive model for DOU using oral examination, clinical, and socioeconomic data. The dataset included 324 diabetic patients, with 127 DOU features. One-hundred-fold cross-validation was employed for model optimization and feature selection. Data preprocessing involved handling missing values, scaling different range values, and feature selection using techniques such as Variance Threshold (VT), Mutual Information (MI), and Variance Inflation Factor (VIF). Four prediction models, Support Vector Machine Classifier (SVC), Multi-layer Perceptron (MLP), Logistic Regression Classifier (LogReg), and Perceptron, were established and evaluated.
resultsThe SVC model outperformed the other models, achieving an accuracy (ACC) of 0.95 and an area under the ROC curve (AUC) of 0.91. The top five features contributing to the model's predictions were the current number of oral ulcers, diminished oral functional capacity, number of decayed or missing teeth, possession of health insurance (commercial), and Low-Density Lipoprotein (LDL-C), accounting for 57.32% of the total importance. Oral examination indicators accounted for 46.46%, serum lipid markers for 6.93%, and sociodemographic factors, personal lifestyles, and cardiovascular diseases also played significant roles.
conclusionThe SVC model demonstrated superior performance and stability, making it suitable for predicting DOU occurrence and development in diabetic patients. This study's innovation lies in the comprehensive evaluation of multiple factors, including oral examinations, physiological indicators, self-management capabilities, and economic factors, to facilitate efficient DOU screening. The findings highlight the potential of ML in improving diagnostic accuracy and enabling timely interventions for DOU, ultimately contributing to better clinical management and patient outcomes. Future research should focus on validating the model across larger, multicenter cohorts and further exploring the long-term impact of ML-guided interventions on DOU management.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.